Literature DB >> 24923267

Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.

Alex Marchand-Austin1, Prasad Rawte2, Baldwin Toye3, Frances B Jamieson1, David J Farrell1, Samir N Patel4.   

Abstract

The local epidemiology of antimicrobial susceptibility patterns in anaerobic bacteria is important in guiding the empiric treatment of infections. However, susceptibility data are very limited on anaerobic organisms, particularly among non-Bacteroides organisms. To determine susceptibility profiles of clinically-significant anaerobic bacteria in Ontario Canada, anaerobic isolates from sterile sites submitted to Public Health Ontario Laboratory (PHOL) for identification and susceptibility testing were included in this study. Using the E-test method, isolates were tested for various antimicrobials including, penicillin, cefoxitin, clindamycin, meropenem, piperacillin-tazobactam and metronidazole. The MIC results were interpreted based on guidelines published by Clinical and Laboratory Standards Institute. Of 2527 anaerobic isolates submitted to PHOL, 1412 were either from sterile sites or bronchial lavage, and underwent susceptibility testing. Among Bacteroides fragilis, 98.2%, 24.7%, 1.6%, and 1.2% were resistant to penicillin, clindamycin, piperacillin-tazobactam, and metronidazole, respectively. Clostridium perfringens was universally susceptible to penicillin, piperacillin-tazobactam, and meropenem, whereas 14.2% of other Clostridium spp. were resistant to penicillin. Among Gram-positive anaerobes, Actinomyces spp., Parvimonas micra and Propionibacterium spp. were universally susceptible to β-lactams. Eggerthella spp., Collinsella spp., and Eubacterium spp. showed variable resistance to penicillin. Among Gram-negative anaerobes, Fusobacterium spp., Prevotella spp., and Veillonella spp. showed high resistance to penicillin but were universally susceptible to meropenem and piperacillin-tazobactam. The detection of metronidazole resistant B. fragilis is concerning as occurrence of these isolates is extremely rare. These data highlight the importance of ongoing surveillance to provide clinically relevant information to clinicians for empiric management of infections caused by anaerobic organisms. Crown
Copyright © 2014. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anaerobes; B. fragilis; Susceptibility data

Mesh:

Substances:

Year:  2014        PMID: 24923267     DOI: 10.1016/j.anaerobe.2014.05.015

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  10 in total

Review 1.  Actinomyces and related organisms in human infections.

Authors:  Eija Könönen; William G Wade
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Infections caused by Fusobacterium in children: a 14-year single-center experience.

Authors:  Oded Shamriz; Dan Engelhard; Violeta Temper; Shoshana Revel-Vilk; Shmuel Benenson; Rebecca Brooks; Ariel Tenenbaum; Polina Stepensky; Benjamin Koplewitz; Michal Kaufmann; Diana Averbuch
Journal:  Infection       Date:  2015-05-01       Impact factor: 3.553

3.  Water Sources in a Zoological Park Harbor Genetically Diverse Strains of Clostridium Perfringens Type A with Decreased Susceptibility to Metronidazole.

Authors:  Sergio Álvarez-Pérez; José L Blanco; Teresa Peláez; Eva Martínez-Nevado; Marta E García
Journal:  Microb Ecol       Date:  2016-04-26       Impact factor: 4.552

4.  First Report of Clostridium lavalense Isolated in Human Blood Cultures.

Authors:  Richard Garceau; Christine Bourque; Louise Thibault; Jean-Charles Côté; Jean Longtin; Marc-Christian Domingo
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-07-10       Impact factor: 2.471

5.  Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan.

Authors:  Yusra Shafquat; Kauser Jabeen; Joveria Farooqi; Kiran Mehmood; Seema Irfan; Rumina Hasan; Afia Zafar
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-14       Impact factor: 4.887

6.  Antibiotic resistance pattern of Bacteroides fragilis isolated from clinical and colorectal specimens.

Authors:  Seyedesomaye Jasemi; Mohammad Emaneini; Zahra Ahmadinejad; Mohammad Sadegh Fazeli; Leonardo A Sechi; Fatemah Sadeghpour Heravi; Mohammad Mehdi Feizabadi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-04-23       Impact factor: 3.944

7.  Clinical Differences in Patients Infected with Fusobacterium and Antimicrobial Susceptibility of Fusobacterium Isolates Recovered at a Tertiary-Care Hospital in Korea.

Authors:  Myungsook Kim; Shin Young Yun; Yunhee Lee; Hyukmin Lee; Dongeun Yong; Kyungwon Lee
Journal:  Ann Lab Med       Date:  2022-03-01       Impact factor: 3.464

8.  Diagnosis and Management of a Cryptoglandular Actinomycotic Fistula-in-Ano: An Update on 7 New Cases and a Review of the Literature.

Authors:  Axel Egal; Isabelle Etienney; Heym Beate; Jean Francois Fléjou; Charles André Cuenod; Patrick Atienza; Pierre Bauer
Journal:  Ann Coloproctol       Date:  2018-06-30

9.  Prevalence and Antimicrobial Resistance of Paeniclostridium sordellii in Hospital Settings.

Authors:  Hanane Zerrouki; Sid-Ahmed Rebiahi; Yamina Elhabiri; Ahlam Fatmi; Sophie Alexandra Baron; Isabelle Pagnier; Seydina M Diene; Jean-Marc Rolain
Journal:  Antibiotics (Basel)       Date:  2021-12-29

10.  Antimicrobial Susceptibility of Clinical Oral Isolates of Actinomyces spp.

Authors:  Alexandra Wolff; Arne C Rodloff; Paul Vielkind; Toralf Borgmann; Catalina-Suzana Stingu
Journal:  Microorganisms       Date:  2022-01-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.